If you look at the TB test kit market and its pricing you would know why TDX was going no where with the TB diagnostic kits. You can more or less judge how valuable the IPs of the TB testing by TDX.
TDX needs to have a new business by Oct. Chapter 1 & 2 filing, new ASX code, consolidation of SP, a CR, new staff. Should be a new company in 2013. Not dissimilar to wht AOP is doing right now.
As for Bayer, as long as TDX needn't pay any compensation for missing the performance criteria in its second test kit, that should be OK. Not hoping for any payment from Bayer.
I only have a few shares left for memory.
Cheers.
CGA Price at posting:
0.2¢ Sentiment: Hold Disclosure: Held
